Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Central Institute Of Mental Health, Mannheim

Clinical trials sponsored by Central Institute Of Mental Health, Mannheim, explained in plain language.

Trials to join now! 3 Not yet finished but already full! 1

CBD shows promise for schizophrenia in new trial

Disease control Ongoing

This phase II trial tests whether cannabidiol (CBD) capsules, added to standard antipsychotic medication, can help people with early schizophrenia recover better and stay on treatment longer. 180 participants receive either CBD or placebo for 26 weeks. The goal is to see if CBD i…

Phase: PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC